InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-6.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Hashim Mir, Directeur Scientifique. Officer active across 1 company, notably Rani Therapeutics Holdings, Inc.. In total, 6 disclosures have been logged. Activity tracked since 9 September 2021. The latest transaction was filed on 27 March 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
139,000 shares0Class A Common StockSEC:0001415889-23-005598:0
4,201 shares@ US$5.9510.4% of flowClass A Common StockSEC:0000899243-23-009584:0
20,334 shares@ US$9.8989.6% of flowClass A Common StockSEC:0001209191-22-049800:0
41,200 shares0Class A Common StockSEC:0001209191-22-021018:0
117,600 shares0Class A Common StockSEC:0001209191-21-055764:0
117,600 shares0Class A Common StockSEC:0001209191-21-055764
6 of 6 declarations
About Hashim Mir
Mir Hashim is the Chief Scientific Officer at Rani Therapeutics Holdings, Inc. He is responsible for leading the company's research and development efforts. With expertise in scientific fields, he plays a crucial role in innovation and the development of new therapies. Mir Hashim is committed to advancing the company's mission by providing cutting-edge therapeutic solutions.
